Incidence and risk factors associated with development of clinical cardiotoxicity in dogs receiving doxorubicin

BACKGROUND: Doxorubicin (DOX) can cause cumulative cardiotoxicity in dogs, but the incidence of clinical cardiotoxicity in dogs receiving DOX has not been determined. HYPOTHESIS/OBJECTIVES: To determine if the duration of DOX infusion influences the incidence of cardiotoxicity, to characterize the i...

Descripción completa

Detalles Bibliográficos
Autores principales: Hallman, Briana E., Hauck, Marlene L., Williams, Laurel E., Hess, Paul R., Suter, Steven E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
SMALL ANIMAL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430885/
https://www.ncbi.nlm.nih.gov/pubmed/30697816
http://dx.doi.org/10.1111/jvim.15414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430885/
https://www.ncbi.nlm.nih.gov/pubmed/30697816
http://dx.doi.org/10.1111/jvim.15414

Ejemplares similares